News Snapshot:
SANTIAGO, April 16 (Xinhua) -- The CoronaVac vaccine developed by Chinese pharmaceutical firm Sinovac is up to 67 percent effective in preventing symptomatic COVID-19, Chile's Ministry of Health said on Friday. Rafael Araos, doctor and advisor to the Undersecretariat of Public Health, announced the efficacy finding during the presentation of the results of a study titled "Effectiveness of the inactivated CoronaVac vaccine against SARS-CoV-2 in Chile." The study also showed the vaccine to be up to 85 percent effective in preventing hospitalization, 89 percent effective in preventing admission to an intensive care unit (ICU), and 80 percent effective in preventing...
